Adugna Solomon, Kebede Yenew, Moges Feleke, Tiruneh Moges
Department of Biochemistry, College of Medicine and Health Sciences, University of Gondar, P.O. Box 1391, Gondar, Ethiopia.
Ethiop Med J. 2007 Jul;45(3):301-6.
The efficacy of mebendazole and albendazole in the treatment of Ascaris lumbricoides and hookworm infections was evaluated in school children in an area with long time exposure for broad spectrum anthelminthic drugs.
Mebendazole exhibited cure rates of 90.6% and 83.5%; egg reduction rates of 96.7% and 94.2% against Ascaris lumbricoides and hookworm infections respectively. Albendazole showed a cure rate of 83.9% and egg reduction rate of 96.3% against Ascaris lumbricoides and a cure rate of 84.2% and egg reduction rate of 95% against hookworm infection. Albendazole appeared to be more effective against hookworm infection (egg reduction rate of 95% versus 94.2%, p = 0.04).
Mebendazole and albendazole showed reduced efficacy against Ascaris lumbricoides and hookworm infections at the recommended doses. This may be a sign for emergence of drug resistance in this region. Care in routine use of the anthelminthes and continuous drug efficacy surveillance is recommended.
在一个长期使用广谱驱虫药的地区,对小学生中甲苯达唑和阿苯达唑治疗蛔虫和钩虫感染的疗效进行评估。
甲苯达唑对蛔虫感染和钩虫感染的治愈率分别为90.6%和83.5%;虫卵减少率分别为96.7%和94.2%。阿苯达唑对蛔虫感染的治愈率为83.9%,虫卵减少率为96.3%;对钩虫感染的治愈率为84.2%,虫卵减少率为95%。阿苯达唑对钩虫感染似乎更有效(虫卵减少率为95%对94.2%,p = 0.04)。
甲苯达唑和阿苯达唑在推荐剂量下对蛔虫和钩虫感染的疗效降低。这可能是该地区出现耐药性的迹象。建议在常规使用驱虫药时谨慎,并持续进行药物疗效监测。